COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,537 Articles (22,881 medRxiv, 8,656 bioRxiv)

Most recent first Previous |  Page 2129: Articles 21281-21290  | Next

CSF of SARS-CoV-2 patients with neurological syndromes reveals hints to understand pathophysiology
Bernard-Valnet, R., Perriot, S., Canales, M., Pizzarotti, B., Caranzano, L., Castro-Jimenez, M., Epiney, J.-B., Vijiala, S., Salvioni Chiabotti, P., Anichini, A., Salerno, A., Jaton, K., Vaucher, J., Perreau, M., Greub, G., Pantaleo, G., Du Pasquier, R.
10.1101/2020.11.01.20217497 — Posted: 2020-11-04
Modelling the impact of COVID-19-related control programme interruptions on progress towards the WHO 2030 target for soil-transmitted helminths
Malizia, V., Giardina, F., Vegvari, C., Bajaj, S., McRae-McKee, K., Anderson, R. M., De Vlas, S. J., Coffeng, L. E.
10.1101/2020.11.01.20220376 — Posted: 2020-11-04
Aerosol and bioaerosol particle size and dynamics from defective sanitary plumbing systems
Gormley, M., Aspray, T. J., Kelly, D. A.
10.1101/2020.11.01.20223974 — Posted: 2020-11-04
Precision shielding for COVID-19: metrics of assessment and feasibility of deployment
Ioannidis, J.
10.1101/2020.11.01.20224147 — Posted: 2020-11-04
Experience from a COVID-19 screening centre of a tertiary care institution: A retrospective hospital-based study
Pradhan, S. K., Sahu, D. P., Sahoo, D. P., Patro, B. K., Singh, A. K., Mohanty, S.
10.1101/2020.11.01.20224105 — Posted: 2020-11-04
SARS-CoV-2 Testing Disparities in Massachusetts
Dryden-Peterson, S., Velasquez, G. E., Stopka, T. J., Davey, S., Lockman, S., Ojikutu, B. O.
10.1101/2020.11.02.20224469 — Posted: 2020-11-04
The CCR5-delta32 variant might explain part of the association between COVID-19 and the chemokine-receptor gene cluster
GOMEZ, J., CUESTA-LLAVONA, E., ALBAICETA, G. M., GARCIA-CLEMENTE, M., LOPEZ-LARREA, C., AMADO, L., LOPEZ-ALONSO, I., HERMIDA, T., ENRIQUEZ, A., GIL, H., ALONSO, B., IGLESIAS, S., SUAREZ-ALVAREZ, B., ALVAREZ, V., COTO, E.
10.1101/2020.11.02.20224659 — Posted: 2020-11-04
The signature features of COVID-19 pandemic in a hybrid mathematical model - implications for optimal work-school lockdown policy
Lazebnik, T., Bunimovich-Mendrazitsky, S.
10.1101/2020.11.02.20224584 — Posted: 2020-11-04
Rapid homogeneous assay for detecting antibodies against SARS-CoV-2
Rusanen, J., Kareinen, L., Levanov, L., Mero, S., Pakkanen, S. H., Kantele, A., Amanat, F., Krammer, F., Hedman, K., Vapalahti, O., Hepojoki, J.
10.1101/2020.11.01.20224113 — Posted: 2020-11-04
A household case evidences shorter shedding of SARS-CoV-2 in naturally infected cats compared to their human owners.
Neira Ramirez, V., Brito, B., Aguero, B., Berrios, F., Valdes, V., Gutierrez, A., Ariyama, N., Espinoza, P., Retamal, P., Holmes, E. C., Gonzalez-reiche, A., Khan, Z., Van de Guchte, A., Dutta, J., Miorin, L., Kehrer, T., Galarce, N., Almonacid, L., Levican, J., van Bakel, H., Garcia-Sastre, A., Medina, R. A.
10.1101/2020.10.31.20220608 — Posted: 2020-11-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).